EDGAR Filing Documents for 0001213900-21-022105

Form 8-K - Current report:

SEC Accession No. 0001213900-21-022105

Filing Date

2021-04-19

Accepted

2021-04-19 16:30:11

Documents

Period of Report

2021-04-19

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea139653-8k_protaratherap.htm	8-K	26392
2	PRESS RELEASE DATED APRIL 19, 2021, ISSUED BY THE REGISTRANT	ea139653ex99-1_protaratherap.htm	EX-99.1	11341
3	GRAPHIC	ex99-1_001.jpg	GRAPHIC	4815
	Complete submission text file	0001213900-21-022105.txt		45968

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337

Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 21834966
SIC: 2836 Biological Products, (No Diagnostic Substances)